Those not achieving target blood glucose levels with metformin or other oral hypoglycemic agents
The Medicare GLP-1 Bridge is a temporary Medicare program that may help certain Medicare Part D patients access specific GLP-1 medications for weight reduction or ongoing weight maintenance
Regarding the participants with MCI or AD, defined based on a clinical dementia rating (CDR) global score of 0.5 or 1, although the 18-month treatment with exenatide was safe and well-tolerated, it did not significantly affect clinical and cognitive measures, nor did it affect MRI cortical thickness and volume or most biomarkers in the cerebrospinal fluid (CSF), plasma, and plasma neuronal extracellular vesicles (EVs)
10.1074/jbc.REV120.014294 J
348 Similarly, in human chondrocytes stimulated by TNF, GLP-1 analogs (such as liraglutide) showed an anti-catabolic effect, reducing the mRNA expression of MMP-3, MMP-13, and ADAMTS5
The most common culprit is norovirus